Antimicrobial Resistance in Escherichia coli Causing Urinary Tract Infection: A Four-Year Study

被引:1
作者
Devnikar, Anushka, V [1 ]
Solabannavar, Shivakumar S. [1 ]
Sonth, Suresh B. [1 ]
Janagond, Anand B. [1 ]
Gokale, Shilpa [1 ]
Bhurle, Arati [1 ]
机构
[1] S Nijalingappa Med Coll, Dept Microbiol, Bagalkot, Karnataka, India
关键词
Urinary Tract Infections; Uropathogenic E. coli; Escherichia coli; Antimicrobial Resistance; EPIDEMIOLOGY;
D O I
10.22207/JPAM.18.1.35
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Urinary tract infections (UTIs) are among the most frequently encountered infections for which individuals seek medical attention. They are usually ascending infections and if left untreated the causative agent can ascend the ureters causing pyelonephritis and, furthermore, enter the bloodstream causing systemic infections and urosepsis. Appropriate treatment prevents progression of disease. Escherichia coli is responsible for 80-95% cases of UTI. This study was undertaken to study the antimicrobial resistance among Escherichia coli isolated from patients suffering from UTI over 4 years at a tertiary level medical facility. A retrospective case series study was conducted. All UTI with significant bacteriuria due to E. coli were included in the study. Identification, speciation and antimicrobial susceptibility testing was done as per standard laboratory practices. A total of 555 strains of Escherichia coli were included in the study. Overall highest resistance rates for E. coli were seen among cephalosporins and fluoroquinolones while least overall resistance was seen for nitrofurantoin. There was gradual rise in resistance for carbapenem over the 4 years. The predominant microorganism responsible for all types of infections affecting the urinary tract is Escherichia coli. Empirical antimicrobial therapy for urinary tract infections may be unsuccessful, as resistance rates among E. coli are constantly increasing. The present study provides information regarding the antimicrobial susceptibility pattern over a period of 4 years. It shows that there is a gradual but consistent decrease in antimicrobial susceptibility among the isolates. Hence, it has become necessary that antimicrobial therapy be based on culture reports. Also, frequent and periodic updating of antimicrobial policy is essential.
引用
收藏
页码:522 / 527
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 2023, Rural population (% of total population)-India
[2]   Treatment of Urinary Tract Infections and Antibiotic Stewardship [J].
Bartoletti, Riccardo ;
Cai, Tommaso ;
Wagenlehner, Florian M. ;
Naber, Kurt ;
Johansen, Truls Erik Bjerklund .
EUROPEAN UROLOGY SUPPLEMENTS, 2016, 15 (04) :81-87
[3]   Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department [J].
Bischoff, Sebastian ;
Walter, Thomas ;
Gerigk, Marlis ;
Ebert, Matthias ;
Vogelmann, Roger .
BMC INFECTIOUS DISEASES, 2018, 18
[4]  
Division of Epidemiology and Communicable Diseases-ICMR, 2021, Antimicrobial Resistance Research and Surveillance Network-Annual Report
[5]   Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies [J].
Falagas, Matthew E. ;
Roussos, Nikos ;
Gkegkes, Loannis D. ;
Rafailidis, Petros I. ;
Karageorgopoulos, Drosos E. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (07) :921-944
[6]   Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data [J].
Fasugba, Oyebola ;
Mitchell, Brett G. ;
Mnatzaganian, George ;
Das, Anindita ;
Collignon, Peter ;
Gardner, Anne .
PLOS ONE, 2016, 11 (10)
[7]   Urinary tract infections: epidemiology, mechanisms of infection and treatment options [J].
Flores-Mireles, Ana L. ;
Walker, Jennifer N. ;
Caparon, Michael ;
Hultgren, Scott J. .
NATURE REVIEWS MICROBIOLOGY, 2015, 13 (05) :269-284
[8]  
Forbes B.A., 2007, BAILEY SCOTTS DIAGNO, V12th
[9]   Epidemiology of urinary tract infections - Transmission and risk factors, incidence, and costs [J].
Foxman, B ;
Brown, P .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (02) :227-+
[10]   Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia [J].
Gudiol, Carlota ;
Cuervo, Guillermo ;
Shaw, Evelyn ;
Pujol, Miquel ;
Carratala, Jordi .
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) :1947-1963